Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

33.65 24.87 22.85 19.86
P/S ratio
1.36 1.27 1.28 1.26
P/FCF ratio
0.00 44.24 14.78 14.05
P/Operating CF
71.24 16.23 118.50 59.63
P/B ratio
2.10 2.07 1.95 1.95
EV/Sales
1.68 1.50 1.52 1.51
EV/EBITDA
11.16 10.50 10.26 9.19
EV/FCF
(25.95) 52.15 17.59 16.85
Current Ratio
1.32 1.32 1.32 1.26
Net Debt/EBITDA
8.10 5.15 8.34 4.51
Debt/Equity
0.68 0.63 0.60 0.55
Earnings Yield
2.97% 4.02% 4.38% 5.03%
Free Cash Flow Yield
(4.76%) 2.26% 6.76% 7.12%
Free Cash Flow per Share
0.18 1.46 0.03 0.27
Book value per Share
13.01 13.11 14.04 13.96
Free Cash Flow
173.20 1,384.61 32.77 259.07
EV/EBIT
23.31 18.79 17.93 15.71
Other line items

Show all line items

Columns are period end dates